Taken together, our preliminary experiments suggest that SPHK2 and mtROS-NLRP3 signal play key roles in the pathogenic processes driven by M1 macrophages in ARDS patients, which can be offset by Opaganib-mediated SPHK2 inhibition. Here, NLRP3 is linked to acute respiratory distress syndrome.